Dianthus Therapeutics DNTH Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's net income?
- Dianthus Therapeutics (DNTH) reported net income of -$40.83M in Q1 2026.
- How has Dianthus Therapeutics's net income changed year-over-year?
- Dianthus Therapeutics's net income decreased by 38.4% year-over-year, from -$29.51M to -$40.83M.
- What is the long-term trend for Dianthus Therapeutics's net income?
- Over 3 years (2021 to 2024), Dianthus Therapeutics's net income has grown at a 6.1% compound annual growth rate (CAGR), from -$71.14M to -$84.97M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.